Regulatory

Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 27 Mar 2024: AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan AstraZeneca Pharma India gains CDSCO approval for Trastuzumab deruxtecan lyophilised powder for solution for infusion 100mg, expanding treatment […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 25 Mar 2024: Bio-Thera Solutions receives FDA clearance for Phase II Study of BAT8006, a Novel ADC Targeting Folate Receptor α Bio-Thera Solutions receives FDA IND clearance for phase II […]

by Sandhya Ramalingam

Continue Reading